Clinical Trial Update: A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tenofovir disoproxil fumarate to adefovir dipivoxil in HBeAg-positive chronic hepatitis B was completed, with results posted in May 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2010-05-19